drugset / Trial / NCT02845778

Pharmacokinetics of Melatonin Niosomes Oral Gel in Healthy Volunteers

NCT02845778

Phase 1/2 Unknown 15 enrolled Khon Kaen University
RandomizedCrossoverTriple-blind

Summary

Melatonin is an endogenous hormone. It is able to promote nighttime sleeping and could induce sleep at daytime in adult and children with the nonpainful diagnostic procedure. However, previous formulation had problems of unstability of product and low oral bioavailability. Melatonin niosomes oral gels are formulated in order to overcome the problem of drug absorption and stability. This study is a randomized, double-blind, three phase crossover design in 15 male volunteers. Melatonin niosomes oral gel will be applied at doses 2.5, 5, and 10 mg with 7 days washout for each period. The pharmacokinetics data, sleep induction effect, and adverse event will be determined.

Timeline

Start
2016-05
Primary completion
2016-08
Completion
2017-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Melatonin Small molecule 2.5 mg Oral
Subject Melatonin Small molecule 5 mg Oral
Subject Melatonin Small molecule 10 mg Oral

Indications

No indication recorded.